Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FNTA | P49354 | 14/20 | 0.46 |
| ▸ | FNTB | P49356 | 14/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | CACNA1G | O43497 | 1/20 | 0.38 |
| ▸ | CACNA1H | O95180 | 1/20 | 0.38 |
| ▸ | CACNA1I | Q9P0X4 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3499472 | 0.94 | FNTA (0.49) | FNTAFNTBKMT2ACACNA1GCACNA1H | |
| Trifluoroacetic Acid SCHEMBL5583305 | 0.85 | FNTA (0.42) | FNTAFNTBCACNA1GCACNA1HCACNA1I | |
| SCHEMBL2364392 | 0.80 | FNTA (0.68) | FNTAFNTB | |
| SCHEMBL3499648 | 0.80 | FNTA (0.70) | FNTAFNTBKMT2ACACNA1GCACNA1H | |
| SCHEMBL6408581 | 0.79 | KMT2A (0.36) | FNTAFNTBKMT2AMEN1 | |
| SCHEMBL3499471 | 0.78 | FNTA (0.44) | FNTAFNTBCACNA1GCACNA1HCACNA1I | |
| SCHEMBL3500085 | 0.78 | FNTA (0.45) | FNTAFNTBCACNA1GCACNA1HCACNA1I | |
| Trifluoroacetic Acid SCHEMBL6275786 | 0.78 | FNTA (0.61) | FNTAFNTBCACNA1GCACNA1HCACNA1I | |
| SCHEMBL3499537 | 0.76 | FNTA (0.49) | FNTAFNTBCACNA1GCACNA1HCACNA1I | |
| SCHEMBL3499620 | 0.75 | CACNA1G (0.47) | FNTAFNTBCACNA1GCACNA1HCACNA1I |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2005089515-A2 | METHODS FOR THE TREATMENT OF SYNUCLEINOPATHIES | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 2005-09-29 | — | — | WO | claimed |